외과용 기기 시장 : 제품별(자본 설비(로봇 시스템, 에너지 발생기), 내시경(경성, 연성), 일회용 소모품, 임플란트), 시술별(일반외과, 심혈관), 최종사용자별(병원, 외래 수술 센터), 지역별 - 세계 예측(-2031년)

The global surgical devices market is projected to reach USD 296.76 billion by 2031, growing from USD 188.74 billion in 2026, at a CAGR of 9.5% during the forecast period.

The growth of the surgical devices market is primarily driven by the rising prevalence of chronic diseases, increasing aging populations, and growing adoption of minimally invasive and robotic-assisted surgeries, which are increasing global surgical procedure volumes. Significant opportunities exist in the expansion of surgical robotics and rapidly growing ambulatory surgery centers, particularly in emerging markets. However, market growth is challenged by the high capital costs associated with advanced surgical technologies, long equipment replacement cycles, and shortages of skilled surgeons and technical personnel required to effectively operate sophisticated surgical systems and equipment.

"By product, the capital equipment segment is expected to grow at the highest CAGR in the surgical devices market during the forecast period."

By product, the surgical devices market includes implants, capital equipment, single-use consumables, surgical endoscopy equipment, reusable surgical instruments, and accessories & ancillary products. Among these, the capital equipment segment is expected to grow the fastest during the forecast period. This growth is driven by increasing adoption of surgical robotic systems, advanced imaging and navigation platforms, surgical visualization systems, operating room integration devices, and energy-based surgical technologies. Healthcare providers are investing in these technologies to improve surgical precision, procedural efficiency, patient outcomes, and minimally invasive surgery capabilities. The growing volume of complex surgical procedures, rising demand for robotic-assisted surgery, and expansion of digital operating rooms are further accelerating capital equipment adoption. Additionally, continuous technological advancements incorporating artificial intelligence, real-time imaging, and data analytics are encouraging hospitals to modernize surgical infrastructure, supporting the rapid growth of the capital equipment segment.

"By end user, the ambulatory surgery centers segment is expected to grow at the highest CAGR in the surgical devices market during the forecast period."

End users categorize the surgical devices market into hospitals, specialty clinics, ambulatory surgery centers, and other end users. Among these, the ambulatory surgery center segment is expected to grow at the highest CAGR in the surgical devices market during the forecast period. This is primarily due to the increasing shift of surgical procedures from hospitals to lower-cost outpatient settings. Advancements in minimally invasive surgery, robotic-assisted procedures, anesthesia techniques, and postoperative care have enabled a growing number of surgeries to be performed safely in ASCs. These facilities offer shorter patient wait times, reduced healthcare costs, faster recovery, and improved operational efficiency compared with traditional hospitals. Additionally, favorable reimbursement trends, increasing patient preference for outpatient care, and rising investments in specialized surgical infrastructure are further driving ASC adoption, supporting strong demand for surgical devices in this setting.

"Asia Pacific is expected to grow at the highest CAGR in the surgical devices market during the forecast period."

The surgical devices market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The Asia Pacific market is expected to experience the highest CAGR due to the region's large patient population, rapidly aging demographics, rising chronic disease burden, and expanding healthcare infrastructure. According to the Journal of the American Medical Directors Association (JAMDA), the prevalence of chronic diseases in China reached 81.1% in 2023, increasing demand for surgical interventions across cardiovascular, oncological, orthopedic, and neurological specialties. Additionally, Japan has one of the world's oldest populations, with more than 10% of its population aged 80 years or older, according to the World Economic Forum. Combined with increasing healthcare expenditure, growing adoption of minimally invasive and robotic-assisted surgeries, and improving access to advanced healthcare services, these factors are accelerating demand for surgical devices across the Asia Pacific region.

A breakdown of the primary participants (supply side) for the surgical devices market referred to in this report is provided below:

• By Company Type: Tier 1 - 35%, Tier 2 - 40%, and Tier 3 - 25%
• By Designation: C-level Executives - 45%, Directors - 35%, and Others - 20%
• By Region: North America - 27%, Europe - 25%, Asia Pacific - 30%, Latin America - 8%, and the Middle East & Africa - 10%

Prominent players in the surgical devices market include Medtronic (Ireland), Boston Scientific Corporation (US), B Braun SE (Germany), Johnson& Johnson (US), Stryker (US), Intuitive Surgical Operations, Inc. (US), CONMED Corporation (US), Olympus Corporation (Japan) Integra LifeSciences Corporation (US), Teleflex Incorporated (US), and among others.

Research Coverage

The report analyzes the surgical devices market and estimates its size and future growth potential across segments by product, type, procedure, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help market leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall ostomy dressing market. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (Rising burden of chronic diseases is accelerating long-term demand for surgical devices, the ageing population is increasing surgical intensity and procedure frequency, minimally invasive and robotic surgery are expanding recurring device demand for surgical device), restraints (High capital intensity and long replacement cycles are restraining the adoption of the advanced surgical platforms, shortage of skilled surgeons and technical expertise), opportunities (Growing transition toward minimally invasive and outpatient surgery is expanding demand for disposable surgical devices), and challenges (Product recalls and device-related safety concerns)
• Market Penetration: Extensive information on products offered by the major players in the global surgical devices market
• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global surgical devices market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by products, type, procedures, end users, and regions
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global surgical devices market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical devices market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 SURGICAL DEVICES MARKET OVERVIEW
• 3.2 NORTH AMERICA: SURGICAL DEVICES MARKET, BY END USER
• 3.3 SURGICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 3.4 SURGICAL DEVICES MARKET: REGIONAL MIX
• 3.5 SURGICAL DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising burden of chronic diseases
    • 4.2.1.2 Rapidly aging population
    • 4.2.1.3 Minimally invasive and robotic surgery
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 High capital intensity and long replacement cycles
    • 4.2.2.2 Shortage of skilled surgeons and technical expertise
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Growing transition toward minimally invasive and outpatient surgery
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Product recalls and device-related safety events
• 4.3 UNMET NEEDS & WHITE SPACES
  • 4.3.1 UNMET NEEDS IN SURGICAL DEVICES MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 BARGAINING POWER OF SUPPLIERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC OUTLOOK
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS & FORECAST
  • 5.2.3 TRENDS IN MINIMALLY INVASIVE SURGERY (MIS) INDUSTRY
  • 5.2.4 TRENDS IN SURGICAL ROBOTS INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE TREND OF SURGICAL DEVICES, BY KEY PLAYER (2023-2025)
  • 5.6.2 AVERAGE SELLING PRICE TREND OF SURGICAL DEVICES, BY REGION (2023-2025)
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT SCENARIO (HS CODE 9018)
  • 5.7.2 EXPORT DATA (HS CODE 9018)
• 5.8 KEY CONFERENCES & EVENTS, 2026-2027
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.10 INVESTMENT & FUNDING SCENARIO
• 5.11 IMPACT OF 2025 US TARIFFS ON SURGICAL DEVICES MARKET
  • 5.11.1 INTRODUCTION
  • 5.11.2 KEY TARIFF RATES
  • 5.11.3 PRICE IMPACT ANALYSIS
  • 5.11.4 IMPACT ON COUNTRIES/REGIONS
    • 5.11.4.1 North America
    • 5.11.4.2 Europe
    • 5.11.4.3 Asia Pacific
  • 5.11.5 END-USE INDUSTRY IMPACT

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 ROBOTIC-ASSISTED & COMPUTER-ASSISTED SURGICAL SYSTEMS
  • 6.1.2 AI-ENABLED SURGICAL SOFTWARE, ANALYTICS, AND SMART DEVICE INTEGRATION
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 DIGITAL SURGICAL WORKFLOW, TRAINING, AND CONNECTED OR ECOSYSTEMS
• 6.3 TECHNOLOGY/PRODUCT ROADMAP
  • 6.3.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
  • 6.3.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
  • 6.3.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
• 6.4 PATENT ANALYSIS
  • 6.4.1 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS
• 6.5 FUTURE APPLICATIONS
  • 6.5.1 AI-ENABLED ROBOTIC & COMPUTER-ASSISTED SURGERY
  • 6.5.2 CONNECTED OPERATING ROOM & DIGITAL SUPPORT ECOSYSTEMS
• 6.6 IMPACT OF AI/GEN AI ON SURGICAL DEVICES MARKET
  • 6.6.1 TOP USE CASES & MARKET POTENTIAL
  • 6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN SURGICAL DEVICES MARKET
  • 6.6.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
  • 6.6.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN SURGICAL DEVICES MARKET

7 SUSTAINABILITY & REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS & COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS
• 7.2 SUSTAINABILITY INITIATIVES
  • 7.2.1 CARBON IMPACT & ECO-APPLICATIONS OF SURGICAL DEVICES MARKET
    • 7.2.1.1 Carbon impact reduction
    • 7.2.1.2 Eco-applications
• 7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
• 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
• 7.5 REIMBURSEMENT ANALYSIS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 KEY BUYING CRITERIA
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
• 8.5 MARKET PROFITABILITY
  • 8.5.1 REVENUE POTENTIAL
  • 8.5.2 COST DYNAMICS
  • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 SURGICAL DEVICES MARKET, BY TYPE

• 9.1 INTRODUCTION
• 9.2 SOFT TISSUE SURGICAL DEVICES
  • 9.2.1 HIGH PROCEDURE VOLUMES ACROSS SOFT TISSUE SURGERIES TO DRIVE DOMINANCE
• 9.3 HARD TISSUE SURGICAL DEVICES
  • 9.3.1 RISING BURDEN OF MUSCULOSKELETAL DISORDERS AND GROWING ADOPTION OF ADVANCED ORTHOPEDIC TECHNOLOGIES TO SUPPORT DEMAND
• 9.4 HYBRID PLATFORMS
  • 9.4.1 GROWING DEMAND FOR VERSATILE SURGICAL TECHNOLOGIES TO SUPPORT SEGMENTAL GROWTH

10 SURGICAL DEVICES MARKET, BY PRODUCT

• 10.1 INTRODUCTION
• 10.2 IMPLANTS
  • 10.2.1 ORTHOPEDIC & SPORTS MEDICINE IMPLANTS
    • 10.2.1.1 High procedure volumes to drive demand for orthopedic & sports medicine implants
  • 10.2.2 CARDIOVASCULAR IMPLANTS
    • 10.2.2.1 High burden of cardiovascular diseases and growing need for structural heart interventions to support demand
  • 10.2.3 SPINAL IMPLANTS
    • 10.2.3.1 Rising burden of degenerative spine disorders to support spinal implant demand
  • 10.2.4 NEUROSURGICAL IMPLANTS
    • 10.2.4.1 Expanding neurological and cerebrovascular disease burden to drive neurosurgical implant demand
  • 10.2.5 DENTAL IMPLANTS
    • 10.2.5.1 Large oral disease and tooth-loss burden to support market growth
  • 10.2.6 SOFT TISSUE & MESH IMPLANTS
    • 10.2.6.1 Growing hernia procedure volumes and abdominal wall reconstruction needs to drive mesh implant adoption
  • 10.2.7 OPHTHALMIC IMPLANTS
    • 10.2.7.1 Growing number of cataract surgeries worldwide to continue to support market growth
  • 10.2.8 OTHER SPECIALTY IMPLANTS
• 10.3 CAPITAL EQUIPMENT
  • 10.3.1 SURGICAL ROBOTIC SYSTEMS
    • 10.3.1.1 Rising minimally invasive procedure volumes and hospital robotic capacity expansion to drive demand
  • 10.3.2 IMAGING & SURGICAL NAVIGATION SYSTEMS
    • 10.3.2.1 Demand for real-time guidance, accuracy, and lower radiation exposure to support adoption
  • 10.3.3 ENERGY GENERATORS & PLATFORMS
    • 10.3.3.1 Persistent need for precise cutting, coagulation, and bleeding control to support demand
  • 10.3.4 OR INTEGRATION & VISUALIZATION SYSTEMS
    • 10.3.4.1 Data visibility, intraoperative image management, and digital workflow control to support demand
  • 10.3.5 SURGICAL MICROSCOPES & EXOSCOPES
    • 10.3.5.1 High-magnification visualization, surgeon ergonomics, and broader microsurgical use to boost growth
  • 10.3.6 INSUFFLATORS & FLUID MANAGEMENT SYSTEMS
    • 10.3.6.1 Expanding minimally invasive and endoscopic procedure volumes to propel market growth
• 10.4 SINGLE-USE CONSUMABLES
  • 10.4.1 SURGICAL STAPLERS & CLIP APPLIERS
    • 10.4.1.1 Growing gastrointestinal, bariatric, and colorectal surgery volumes to fuel growth
  • 10.4.2 SUTURES & WOUND CLOSURE PRODUCTS
    • 10.4.2.1 Rising surgical procedure volumes and trauma-related wound management needs to fuel market
  • 10.4.3 SINGLE-USE ENERGY DEVICES
    • 10.4.3.1 Growing minimally invasive and robot-assisted surgery volumes to drive utilization of single-use energy devices
  • 10.4.4 TROCARS & ACCESS DEVICES
    • 10.4.4.1 Rising minimally invasive surgery volumes across multiple specialties to contribute to market growth
  • 10.4.5 HEMOSTATS & SEALANTS
    • 10.4.5.1 Growing volumes of cardiovascular, orthopedic, and complex surgical procedures to drive market growth
• 10.5 SURGICAL ENDOSCOPY EQUIPMENT
  • 10.5.1 RIGID ENDOSCOPES
    • 10.5.1.1 Expanding minimally invasive surgical procedure volumes across multiple specialties to fuel growth
  • 10.5.2 FLEXIBLE ENDOSCOPES
    • 10.5.2.1 Growing volumes of cardiovascular, orthopedic, and complex surgical procedures to boost demand
• 10.6 REUSABLE SURGICAL INSTRUMENTS
  • 10.6.1 POWERED INSTRUMENTS
    • 10.6.1.1 Increasing complex reconstructive procedure volumes to drive demand
  • 10.6.2 HANDHELD INSTRUMENTS
    • 10.6.2.1 Broad utilization across general, cardiovascular, oncologic, and specialty surgeries to sustain demand
• 10.7 ACCESSORIES & ANCILLARY PRODUCTS

11 SURGICAL DEVICES MARKET, BY PROCEDURE

• 11.1 INTRODUCTION
• 11.2 ORTHOPEDICS
  • 11.2.1 RISING BURDEN OF MUSCULOSKELETAL DISORDERS TO DRIVE GROWTH OF ORTHOPEDIC SURGICAL DEVICES SEGMENT
• 11.3 CARDIOVASCULAR
  • 11.3.1 RISING CARDIOVASCULAR DISEASE BURDEN TO DRIVE SUSTAINED DEMAND FOR CARDIOVASCULAR SURGICAL DEVICES
• 11.4 GENERAL SURGERY
  • 11.4.1 HIGH SURGICAL PROCEDURE VOLUMES ACROSS MULTIPLE SPECIALTIES TO DRIVE DEMAND FOR GENERAL SURGERY DEVICES
• 11.5 GASTROINTESTINAL
  • 11.5.1 RISING BURDEN OF GASTROINTESTINAL DISORDERS TO DRIVE DEMAND FOR GASTROINTESTINAL SURGICAL PROCEDURES
• 11.6 NEUROLOGY
  • 11.6.1 RISING BURDEN OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH
• 11.7 GYNECOLOGY
  • 11.7.1 GROWING BURDEN OF GYNECOLOGICAL CANCERS TO DRIVE DEMAND FOR GYNECOLOGICAL SURGICAL PROCEDURES
• 11.8 UROLOGY
  • 11.8.1 RISING PREVALENCE OF CHRONIC KIDNEY DISEASE AND UROLOGICAL CANCERS TO BOOST MARKET
• 11.9 DENTAL
  • 11.9.1 GROWING DEMAND FOR DENTAL IMPLANTS AND COSMETIC DENTISTRY TO ACCELERATE SEGMENT GROWTH
• 11.10 ENT
  • 11.10.1 RISING INCIDENCE OF ENT DISORDERS TO DRIVE GROWTH
• 11.11 PEDIATRICS
  • 11.11.1 RISING ULCERATIVE COLITIS PREVALENCE TO DRIVE SEGMENTAL GROWTH
• 11.12 OTHER PROCEDURES

12 SURGICAL DEVICES MARKET, BY END USER

• 12.1 INTRODUCTION
• 12.2 HOSPITALS
  • 12.2.1 HIGH SURGICAL PROCEDURE VOLUMES AND ADOPTION OF ADVANCED SURGICAL TECHNOLOGIES TO SUPPORT HOSPITAL DOMINANCE
• 12.3 AMBULATORY SURGICAL CENTERS
  • 12.3.1 GROWING SHIFT TOWARD COST-EFFECTIVE OUTPATIENT SURGERIES AND MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH
• 12.4 SPECIALTY CLINICS
  • 12.4.1 RISING DEMAND FOR SPECIALIZED SURGICAL CARE TO SUPPORT SEGMENT GROWTH
• 12.5 OTHER END USERS

13 SURGICAL DEVICES MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 13.2.2 US
    • 13.2.2.1 US to hold major share in North American surgical devices market
  • 13.2.3 CANADA
    • 13.2.3.1 Growing chronic disease burden and aging population to support Canada's market growth
• 13.3 EUROPE
  • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 13.3.2 GERMANY
    • 13.3.2.1 Germany held major share in European surgical devices market
  • 13.3.3 UK
    • 13.3.3.1 Growing burden of musculoskeletal and cardiovascular diseases to support surgical device demand in UK
  • 13.3.4 FRANCE
    • 13.3.4.1 Rising burden of cardiovascular disease and cancer to aid market growth
  • 13.3.5 ITALY
    • 13.3.5.1 Rising cancer burden and growing demand for advanced surgical care support to drive demand
  • 13.3.6 SPAIN
    • 13.3.6.1 growing aging population and rising burden of chronic diseases to aid market growth
  • 13.3.7 REST OF EUROPE
• 13.4 ASIA PACIFIC
  • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 13.4.2 CHINA
    • 13.4.2.1 China held major share of Asia Pacific surgical devices market
  • 13.4.3 JAPAN
    • 13.4.3.1 Rising aging population and rising burden of cancer to drive market growth
  • 13.4.4 INDIA
    • 13.4.4.1 Rising chronic disease burden, aging population, and expanding healthcare access to drive rapid market growth
  • 13.4.5 AUSTRALIA
    • 13.4.5.1 High burden of cardiovascular and musculoskeletal disorders to support surgical device demand
  • 13.4.6 SOUTH KOREA
    • 13.4.6.1 Aging population and rising cancer burden to support surgical device demand in South Korea
  • 13.4.7 REST OF ASIA PACIFIC
• 13.5 LATIN AMERICA
  • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 13.5.2 BRAZIL
    • 13.5.2.1 Brazil to holds largest share in Latin American market
  • 13.5.3 MEXICO
    • 13.5.3.1 Rising chronic disease burden and growing medical tourism to support market expansion in Mexico
  • 13.5.4 REST OF LATIN AMERICA
• 13.6 MIDDLE EAST & AFRICA
  • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 13.6.2 GCC COUNTRIES
    • 13.6.2.1 Rising cancer incidence and strong healthcare infrastructure to aid market growth
  • 13.6.3 REST OF MIDDLE EAST & AFRICA

14 COMPETITIVE LANDSCAPE

• 14.1 INTRODUCTION
• 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL DEVICES MARKET
• 14.3 REVENUE ANALYSIS, 2021-2025
• 14.4 MARKET SHARE ANALYSIS, 2025
  • 14.4.1 GLOBAL SURGICAL ROBOTS MARKET SHARE ANALYSIS, 2025
  • 14.4.2 GLOBAL ENERGY GENERATORS MARKET SHARE ANALYSIS, 2025
  • 14.4.3 GLOBAL SURGICAL SUTURES MARKET SHARE ANALYSIS, 2025
  • 14.4.4 GLOBAL SURGICAL STAPLERS MARKET SHARE ANALYSIS, 2025
• 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 14.5.1 STARS
  • 14.5.2 EMERGING LEADERS
  • 14.5.3 PERVASIVE PLAYERS
  • 14.5.4 PARTICIPANTS
  • 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 14.5.5.1 Company footprint
    • 14.5.5.2 Region footprint
    • 14.5.5.3 Type footprint
    • 14.5.5.4 Product footprint
    • 14.5.5.5 Procedure footprint
    • 14.5.5.6 End-user footprint
• 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 14.6.1 PROGRESSIVE COMPANIES
  • 14.6.2 RESPONSIVE COMPANIES
  • 14.6.3 DYNAMIC COMPANIES
  • 14.6.4 STARTING BLOCKS
  • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 14.6.5.1 Detailed list of key startups/SMEs
    • 14.6.5.2 Competitive benchmarking of key startups/SMEs
• 14.7 COMPANY VALUATION & FINANCIAL METRICS
  • 14.7.1 FINANCIAL METRICS
  • 14.7.2 COMPANY VALUATION
• 14.8 BRAND/PRODUCT COMPARISON
• 14.9 COMPETITIVE SCENARIO
  • 14.9.1 PRODUCT LAUNCHES & APPROVALS
  • 14.9.2 DEALS
  • 14.9.3 EXPANSIONS

15 COMPANY PROFILES

• 15.1 KEY PLAYERS
  • 15.1.1 MEDTRONIC PLC
    • 15.1.1.1 Business overview
    • 15.1.1.2 Products offered
    • 15.1.1.3 Recent developments
      • 15.1.1.3.1 Product approvals
      • 15.1.1.3.2 Other developments
    • 15.1.1.4 MnM view
      • 15.1.1.4.1 Right to win
      • 15.1.1.4.2 Strategic choices
      • 15.1.1.4.3 Weaknesses & competitive threats
  • 15.1.2 JOHNSON & JOHNSON
    • 15.1.2.1 Business overview
    • 15.1.2.2 Products offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Product launches & approvals
      • 15.1.2.3.2 Deals
      • 15.1.2.3.3 Expansions
    • 15.1.2.4 MnM view
      • 15.1.2.4.1 Right to win
      • 15.1.2.4.2 Strategic choices
      • 15.1.2.4.3 Weaknesses & competitive threats
  • 15.1.3 STRYKER CORPORATION
    • 15.1.3.1 Business overview
    • 15.1.3.2 Products offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Deals
  • 15.1.4 B. BRAUN
    • 15.1.4.1 Business overview
    • 15.1.4.2 Products offered
    • 15.1.4.3 Recent developments
      • 15.1.4.3.1 Deals
      • 15.1.4.3.2 Expansions
    • 15.1.4.4 MnM view
      • 15.1.4.4.1 Right to win
      • 15.1.4.4.2 Strategic choices
      • 15.1.4.4.3 Weaknesses & competitive threats
  • 15.1.5 INTUITIVE SURGICAL
    • 15.1.5.1 Business overview
    • 15.1.5.2 Products offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Product approvals
      • 15.1.5.3.2 Expansions
  • 15.1.6 SIEMENS HEALTHINEERS AG
    • 15.1.6.1 Business overview
    • 15.1.6.2 Products offered
    • 15.1.6.3 Recent developments
      • 15.1.6.3.1 Product launches & approvals
      • 15.1.6.3.2 Expansions
  • 15.1.7 OLYMPUS CORPORATION
    • 15.1.7.1 Business overview
    • 15.1.7.2 Products offered
    • 15.1.7.3 Recent developments
      • 15.1.7.3.1 Product launches & approvals
  • 15.1.8 ZIMMER BIOMET HOLDINGS, INC.
    • 15.1.8.1 Business overview
    • 15.1.8.2 Products offered
    • 15.1.8.3 Recent developments
      • 15.1.8.3.1 Product launches & approvals
      • 15.1.8.3.2 Deals
  • 15.1.9 BOSTON SCIENTIFIC CORPORATION
    • 15.1.9.1 Business overview
    • 15.1.9.2 Products offered
    • 15.1.9.3 Recent developments
      • 15.1.9.3.1 Product launches & approvals
  • 15.1.10 CONMED CORPORATION
    • 15.1.10.1 Business overview
    • 15.1.10.2 Products offered
    • 15.1.10.3 Recent developments
      • 15.1.10.3.1 Product launches
      • 15.1.10.3.2 Expansions
• 15.2 OTHER PLAYERS
  • 15.2.1 BAXTER INTERNATIONAL INC.
  • 15.2.2 HEALTHIUM MEDTECH LIMITED
  • 15.2.3 ABBOTT
  • 15.2.4 GLOBUS MEDICAL, INC.
  • 15.2.5 BECTON, DICKINSON AND COMPANY
  • 15.2.6 SMITH+NEPHEW
  • 15.2.7 MICROPORT SCIENTIFIC CORPORATION
  • 15.2.8 INTEGRA LIFESCIENCES
  • 15.2.9 COOK MEDICAL
  • 15.2.10 ARTHREX, INC.
  • 15.2.11 ADVANCED MEDICAL SOLUTIONS GROUP PLC
  • 15.2.12 ASPEN SURGICAL PRODUCTS, INC.
  • 15.2.13 FUJIFILM HOLDINGS CORPORATION
  • 15.2.14 KARL STORZ
  • 15.2.15 STERIS PLC

16 RESEARCH METHODOLOGY

• 16.1 RESEARCH DATA
  • 16.1.1 SECONDARY DATA
    • 16.1.1.1 Key data from secondary sources
  • 16.1.2 PRIMARY DATA
    • 16.1.2.1 Key data from primary sources
    • 16.1.2.2 Key industry insights
• 16.2 MARKET SIZE ESTIMATION
• 16.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 16.4 MARKET RANKING ANALYSIS
• 16.5 STUDY ASSUMPTIONS
• 16.6 RESEARCH LIMITATIONS
  • 16.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 16.6.2 SCOPE-RELATED LIMITATIONS
• 16.7 RISK ASSESSMENT

17 APPENDIX

• 17.1 DISCUSSION GUIDE
• 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 17.3 CUSTOMIZATION OPTIONS
• 17.4 RELATED REPORTS
• 17.5 AUTHOR DETAILS